Display options
Share it on
Full text links
Nature Publishing Group

Nature. 1988 Feb 11;331(6156):525-7. doi: 10.1038/331525a0.

A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors.

Nature

P Ponte, P Gonzalez-DeWhitt, J Schilling, J Miller, D Hsu, B Greenberg, K Davis, W Wallace, I Lieberburg, F Fuller

Affiliations

  1. California Biotechnology, Inc., Mountain View 94043.

PMID: 2893289 DOI: 10.1038/331525a0

Abstract

The amyloid proteins isolated from neuritic plaques and the cerebrovasculature of Alzheimer's disease are self-aggregating moieties termed A4 protein and beta-protein, respectively. A putative A4 amyloid precursor (herein termed A4(695] has been characterized by analysis of a human brain complementary DNA. We report here the sequence of a closely related amyloid cDNA, A4(751), distinguished from A4(695) by the presence of a 168 base-pair (bp) sequence which adds 57 amino acids to, and removes one residue from, the predicted A4(695) protein. The peptide predicted from this insert is very similar to the Kunitz family of serine proteinase inhibitors. The two A4-specific messenger RNAs are differentially expressed: in a limited survey, A4(751) mRNA appears to be ubiquitous, whereas A4(695) mRNA has a restricted pattern of expression which includes cells from neuronal tissue. These data may have significant implications for understanding amyloid deposition in Alzheimer's disease.

Cited by

Substances

MeSH terms

Publication Types

LinkOut - more resources